Now this New York Times article highlights a study at the University of Zurich, where 9 patients who could swim before DBS lost that skill post- surgery. It quotes Dr. Michael Okun, medical director of the Parkinson’s Foundation, saying the report leaves doctors with more questions than answers. He also happens…
Tyler’s Hope for a Dystonia Cure hosted The Season of Hope on Saturday, Dec. 7 — an annual 5K/15K fundraiser run to benefit the battle against dystonia and other movement disorders.
A lifelong swimmer had recently received an electronic brain implant to control tremors and other symptoms of Parkinson’s disease, and somehow the signals from the device had knocked out his ability to coordinate his arms and legs for swimming.
Gunduz was featured on the cover of the magazine CrossLink for her contributions to the field, for breaking barriers, and for receiving the Presidential Early Career Award for Scientists and Engineers (PECAS).
In summer 2020, the Norman Fixel Institute for Neurological Diseases at UF Health will welcome Juan B. Toledo, M.D., Ph.D., a neurology resident at Houston Methodist and recipient of the Edmond J. Safra Fellowship in Movement Disorders — a collaboration between The Michael J. Fox Foundation for Parkinson’s Research and…
Phishing is the most common form of cyberattack and still growing. The reason it’s so effective, according to research at the University of Florida and Google, is that it takes advantage of how the human brain works.
Malú Tansey, Ph.D., director of UF’s Center for Translational Research in Neurodegenerative Disease, was featured on a TV newscast, sharing insights into the role of inflammation in dementia.
Michael Okun helps patients manage debilitating diseases. Read the bio on Dr. Okun who helps patients with Parkinson’s disease, dystonia and other movement disorders.
A research team led by UF’s David Vaillancourt, Ph.D., used a non-invasive MRI method with 1,002 patients to develop an automated system to accurately diagnose Parkinson’s disease and related but different neurodegenerative disorders.
The proceedings of the Sixth Annual Think Tank recapitulate progress in applications of neurotechnology, neurophysiology and emerging techniques for the treatment of a range of psychiatric and neurological conditions including Parkinson’s disease, essential tremor, Tourette syndrome, epilepsy, cognitive disorders, and addiction.